Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: a multicenter retrospective cohort study from 2007 to 2015

BACKGROUND: Triple-drug regimens are the gold standard for HIV therapy. Nucleos(t)ide reverse transcriptase inhibitors (NRTIs) reducing regimens are used to decrease drugs toxicity, exposure and costs. Aim of our study was to evaluate trends of biochemical and inflammatory indices in patients switch...

Descripción completa

Detalles Bibliográficos
Autores principales: Quiros-Roldan, Eugenia, Magro, Paola, Raffetti, Elena, Izzo, Ilaria, Borghetti, Alessandro, Lombardi, Francesca, Saracino, Annalisa, Maggiolo, Franco, Castelli, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020212/
https://www.ncbi.nlm.nih.gov/pubmed/29940869
http://dx.doi.org/10.1186/s12879-018-3198-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020212/
https://www.ncbi.nlm.nih.gov/pubmed/29940869
http://dx.doi.org/10.1186/s12879-018-3198-2

Ejemplares similares